Brief: NeoGenomics Q2 Gross Profit USD 59.9 Mln
08/08/2023 12:03
Aug 8 (Reuters) - NeoGenomics Q2 adjusted net income USD -7 million. * Q2 operating expenses USD 90 million * Q2 net income USD -24 million * Q2 adjusted EBITDA USD -2 million * Q2 revenue USD 147 million vs. IBES estimate USD 137.4 million * Q2 gross profit USD 59.9 million * Q2 adjusted gross margin 44.1% * Q2 gross margin 40.8%
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring